Chordoma Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Chordoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

ChondrosarcomaBone SarcomaChordoma+2 more
Mayo Clinic72 enrolled3 locationsNCT05033288
Recruiting
Phase 1Phase 2

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

OsteosarcomaEwing SarcomaNeuroblastoma+10 more
University of Florida27 enrolled1 locationNCT06625190
Recruiting
Not Applicable

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

ChondrosarcomaChordoma
Quironsalud20 enrolled1 locationNCT05861245
Recruiting
Phase 1Phase 2

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

Epithelioid SarcomaAtypical Teratoid/Rhabdoid TumorChordoma+4 more
Susan Chi, MD49 enrolled3 locationsNCT05407441
Recruiting

Long-Term Longitudinal QoL in Patients Undergoing EEA

ChondrosarcomaMeningiomaPituitary Tumor+5 more
Ohio State University400 enrolled1 locationNCT04087902
Recruiting
Not Applicable

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

OsteosarcomaEwing SarcomaChondrosarcoma+1 more
Centre Antoine Lacassagne106 enrolled1 locationNCT06029218
Recruiting

Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas

Proton TherapyPET/CTChondrosarcoma+3 more
Leiden University Medical Center40 enrolled2 locationsNCT04832620
Recruiting
Not Applicable

Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors

Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma
Hospices Civils de Lyon250 enrolled21 locationsNCT02838602